Telegram RegisterThe public register of Telegram
Telegram profile photo for 팔칠사공스토너 실전투자 인사이트

Channel

팔칠사공스토너 실전투자 인사이트

@stoner8740

On this record: Topic · Observations · Channels linked by matching posts · Growth · Engagement · What this channel posts · Posts · Posts edited after publishing · Citations · Cite this entry

10,873subscribers

-155 since we began measuring on 6 August 2026

Risers and fallers across the register · movement among entries of 10,000–31,623.

Register entry

Telegram ID-1002378754614
TypeChannel
Username@stoner8740
Description전업투자자의 생생한 매매현황 기업분석 주식뉴스 뷰를 실시간 말씀드립니다. ※ 이 채널의 모든 메세지는 매수 매도 추천채널이 아닙니다. 모든 메세지의 정보나 데이터는 어떠한 정확성도 검증이 없습니다. 투자책임 손실 등 모든 것은 투자자 본인에게 귀속됩니다. 전업투자자의 시각에서 저렇게 매매하는구나 실시간 뉴스라든지 뉴스에 대한 매수매도를 저렇게 판단하는구나 그냥 구경만 하시면되겠습니다. 절대 매수/매도 추천이 아닙니다.
CreatedBetween 1 September 2024 and 31 March 2025 — estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded6 August 2026
Last confirmed live12 November 2026
Measurements held60
Confirmed unchanged1 time, most recently 12 November 2026
On Telegramt.me/stoner8740

Topic

Crypto & trading — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 11 September 2026 and assigned it the closest of 31 fixed categories, at 83% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and the other topics.

Observations

These are measurements, not verdicts. Each one below states something we counted, alongside the evidence it was counted from, so you can check it rather than take it. None of them is graded: every observation this register holds is recorded at severity 0, because the precision of the detectors behind them has not been measured yet, and a rating we cannot support is worse than none. Read each as a fact about the data, not as a judgement about the channel. How we measure.

Content that also appears on other registered channels

Posts published here appear in near-verbatim form on 9 other registered channels. This entry also forms a group of 2 channels linked by matching posts. The matching is on the text itself, not on Telegram’s forward marker, so it finds a copy whether or not it was labelled as one.

Matching posts — open both and compare (6 of the pairs behind the counts below)
Posted firstThenOverlapGap
@stoner8740/16210 · this entry7 Aug 2026, 08:34 UTC@pharmbiohana/110767 Aug 2026, 08:37 UTC1.002 minutes
@stoner8740/16210 · this entry7 Aug 2026, 08:34 UTC@bbong_tta/224277 Aug 2026, 08:35 UTC1.0072 seconds
@bbong_tta/2260421 Aug 2026, 07:13 UTC@stoner8740/16466 · this entry21 Aug 2026, 07:15 UTC1.002 minutes
@stoner8740/16667 · this entry2 Sept 2026, 04:26 UTC@bbong_tta/227032 Sept 2026, 04:26 UTC1.00under a minute
@stoner8740/17746 · this entry9 Nov 2026, 12:18 UTC@bbong_tta/237149 Nov 2026, 12:22 UTC1.004 minutes
@stoner8740/17762 · this entry10 Nov 2026, 07:22 UTC@bbong_tta/2373710 Nov 2026, 07:28 UTC1.006 minutes
Channels this entry shares post bodies with, where at least one matching post pair has no forward credit between the two channels, or to a common source, recorded in our data
ChannelMatching postsText overlapTypical gapPublished first
@pharmbiohana26 (8/8 hand-verifiable sample passed)1.0020 minutesthis entry (19–7)
@bbong_tta8 (8/8 hand-verifiable sample passed)1.004 minutesthis entry (7–1)
@Ten_level11 (8/8 hand-verifiable sample passed)1.0072 seconds@Ten_level (6–5)
@bio_shinhan11 (8/8 hand-verifiable sample passed)1.002 minutes@bio_shinhan (9–2)
@Yeouido_Lab17 (8/8 hand-verifiable sample passed)1.007 minutesthis entry (13–4)
@mootda5 (5/5 hand-verifiable sample passed)1.0072 secondsthis entry (3–2)
@bioksm7 (7/7 hand-verifiable sample passed)1.0014 minutesthis entry (4–3)
@K_biopharma1st6 (6/6 hand-verifiable sample passed)1.0018 minutesthis entry (4–2)
@huhpharm7 (7/7 hand-verifiable sample passed)1.004 minutesthis entry (6–1)

Text overlap is the Jaccard coefficient over the set of distinct three-word phrases in the two bodies: 1.00 is identical wording, and the threshold for counting a pair at all is 0.70. Candidates are generated by simhash LSH (4 x 16-bit bands, exact Hamming <= 3) verified against the bodies with Jaccard over the SET of distinct 3-word shingles. Published first counts which side of each matching pair carries the earlier timestamp — in this corpus, which is the limitation directly below.

What this cannot establish

MEASURED, DOMINANT ERROR SOURCE: a post ingested before 2026-08-06 may have carried a forward header that was not recorded. A 45-pair hand-check against live t.me pages found 14 (31%) where the live page shows a forward header naming the other channel and the database has none, plus 4 more (9%) naming a third party. The text match itself was wrong 0 times out of 45. Read attribution_capture.items_in_trusted_window before treating the unattributed count as a claim.

Telegram lets a channel forward a post with a header naming the source, and we only began reliably recording that header on 2026-08-06. 9 of the 10 matches recorded here fall after that date and carried no header when we read them. The rest predate reliable capture and are not evidence either way.

“Published first” means first in this corpus. We hold 285 comparable posts for this entry, running 5 August 2026 to 11 November 2026. A channel we have read one page deep will look younger than a neighbour we have read in full, and the order would flip with no change in the underlying facts.

The detector’s own notes on this observation, as it recorded them. Names in this_style are fields of the underlying evidence record, which the plain-English paragraphs above read out for this entry.

  • Verbatim republication has three causes and the text separates only two: a clone/mirror, unattributed copy-paste, or BOTH channels copying a common third source that neither attributes. The spread filter (content held by at most 8 channels) reduces the third and does not remove it.
  • 'Earliest' means earliest IN THIS CORPUS. A channel ingested one page deep will look younger than a neighbour ingested in full; corpus_coverage above is there to be checked before the direction is believed.
  • shared_verified_est extrapolates the sampled pass rate over the full narrow match count; sampled/passed are the numbers actually measured.
  • Absence of a forward header is not proof of intent: Telegram lets a channel disable forward attribution, and a credit written in the body is not parsed as attribution here (mention_edge_either_way above is the closest available signal).

Of the group of 2 channels, the one whose matching posts we hold earliest is @stoner8740 — which is this entry. That is a statement about our reading window, not a claim of authorship.

Recorded under the keys clone_copy · clone_mutual · clone_source, last confirmed 12 November 2026. An observation that a later pass no longer finds is cleared, and a cleared observation is removed from this page rather than being shown struck through — we do not keep publishing a claim we have withdrawn. Dispute an observation.

Channels linked by matching posts

This channel is in a group of 2 registered channels linked by matching posts. Links are found by comparing text fingerprints across every channel on the register.

Which channel, if either, published first is deliberately not shown in this list. “First” could only mean first in our own crawl, which depends on how deep we happened to reach into each channel’s history, not on when the content was actually first posted. Our one hand-check read 45 of the highest-confidence flagged pairs against the live Telegram pages. In 18 of them the live page showed a “Forwarded from” credit that our database had no record of, so reading that pair as an unattributed copy was wrong; the check did not measure who published first. This list is ordered by subscriber count, the same as every other listing on this site, never by which channel we think came first. Near-verbatim matching has several ordinary explanations besides copying — a channel mirroring itself, an unattributed repost, or two channels independently repeating the same wire story — and this measurement cannot tell those apart. How this is measured.

Growth

10,87311,05110,9626 August 2026 — 11,028 subscribers7 August 2026 — 11,034 subscribers7 August 2026 — 11,030 subscribers8 August 2026 — 11,025 subscribers9 August 2026 — 11,029 subscribers10 August 2026 — 11,027 subscribers12 August 2026 — 11,023 subscribers16 August 2026 — 11,026 subscribers17 August 2026 — 11,027 subscribers18 August 2026 — 11,023 subscribers19 August 2026 — 11,051 subscribers20 August 2026 — 11,049 subscribers21 August 2026 — 11,039 subscribers23 August 2026 — 11,016 subscribers25 August 2026 — 11,008 subscribers26 August 2026 — 11,013 subscribers27 August 2026 — 11,017 subscribers28 August 2026 — 11,018 subscribers29 August 2026 — 11,016 subscribers30 August 2026 — 11,013 subscribers31 August 2026 — 11,009 subscribers1 September 2026 — 11,005 subscribers2 September 2026 — 10,993 subscribers3 September 2026 — 10,987 subscribers4 September 2026 — 10,988 subscribers7 September 2026 — 10,980 subscribers10 September 2026 — 10,981 subscribers12 September 2026 — 10,982 subscribers14 September 2026 — 10,987 subscribers16 September 2026 — 11,022 subscribers18 September 2026 — 11,035 subscribers25 September 2026 — 11,012 subscribers3 October 2026 — 10,988 subscribers8 October 2026 — 10,966 subscribers12 October 2026 — 10,934 subscribers14 October 2026 — 10,926 subscribers16 October 2026 — 10,928 subscribers17 October 2026 — 10,929 subscribers18 October 2026 — 10,925 subscribers19 October 2026 — 10,924 subscribers20 October 2026 — 10,913 subscribers21 October 2026 — 10,912 subscribers22 October 2026 — 10,910 subscribers24 October 2026 — 10,909 subscribers24 October 2026 — 10,910 subscribers27 October 2026 — 10,905 subscribers28 October 2026 — 10,900 subscribers29 October 2026 — 10,896 subscribers30 October 2026 — 10,894 subscribers31 October 2026 — 10,895 subscribers1 November 2026 — 10,892 subscribers2 November 2026 — 10,883 subscribers3 November 2026 — 10,882 subscribers4 November 2026 — 10,886 subscribers5 November 2026 — 10,888 subscribers6 November 2026 — 10,890 subscribers7 November 2026 — 10,887 subscribers8 November 2026 — 10,884 subscribers10 November 2026 — 10,875 subscribers12 November 2026 — 10,873 subscribers6 August 202612 November 2026
60 measurements spanning 98 days, net -155. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 10,846–11,078 and does not start at zero.
Measurement log — every subscribers count we have recorded, most recent 20 of 60
Measured (UTC)SubscribersChange
12 Nov 2026, 01:4110,873-2
10 Nov 2026, 02:5010,875-9
8 Nov 2026, 16:2010,884-3
7 Nov 2026, 06:4410,887-3
6 Nov 2026, 08:0910,890+2
5 Nov 2026, 09:4010,888+2
4 Nov 2026, 11:1610,886+4
3 Nov 2026, 07:5710,882-1
2 Nov 2026, 07:3610,883-9
1 Nov 2026, 06:1910,892-3
31 Oct 2026, 04:5110,895+1
30 Oct 2026, 04:3010,894-2
29 Oct 2026, 06:1010,896-4
28 Oct 2026, 02:5010,900-5
27 Oct 2026, 01:4910,905-5
24 Oct 2026, 21:3010,910+1
24 Oct 2026, 00:0810,909-1
22 Oct 2026, 22:1610,910-2
21 Oct 2026, 21:4610,912-1
20 Oct 2026, 16:0910,913first reading

Engagement

511 posts held, back to 5 August 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 60 pages of Telegram’s post history, 20 posts per page.

ERR · 30 days
23.0%
avg views ÷ 10,873 subscribers
Avg views / post
2,500
136 posts measured
Reaction rate
—
this channel exposes no reaction counts
Posts in window
136
of 511 held

ERR is average views per post over the last 30 days divided by subscribers, the definition TGStat uses, so this figure is comparable with the one you will see elsewhere. It falls structurally as a channel grows: a high ERR on a small channel and a low one on a large channel describe reach mathematics, not quality. We publish the figure and the sample it came from and pass no verdict on it.

ER is defined industry-wide as (forwards + reactions + comments) ÷ views — note the denominator is views, not subscribers. Telegram’s public web preview carries views and reactions but not forward or comment counts, so the reaction rate above is the reactions term only and is therefore a floor: the true ER for this channel is higher by an amount we have not measured and will not estimate.

What these figures were computed from
WindowRolling 30 days · latest post in window 12 November 2026
Posts held511 (5 August 2026 – 12 November 2026)
Views total340,170
Reactions total—
Forwards / commentsnot exposed by the public surface — not measured, not estimated
Readings taken12 Nov 2026, 10:06 UTC

Views are a single reading per post, taken at the time above. A post published in the last day or two is still accumulating views, which pulls the 30-day average down slightly. That is a property of the standard definition rather than a fault in it, so we keep the definition rather than “correcting” the number into something nobody can reproduce.

Precision. Telegram publishes view counts on its public widget in short form — 8.12K, 3.7M — so any reading at or above 1,000 reaches us rounded to three significant figures, and only counts below 1,000 are exact. Averages and rates derived from them are shown to the same precision rather than to the unit: a figure like 3,701,250 would assert digits nobody measured.

Reaction counts are published per emoji and rounded the same way, so a total below 1,000 is exact and a larger one is a sum that may carry a rounded component from each emoji above 1,000. Because it is a sum, it does not look rounded — read a large reaction total as three significant figures per contributing emoji rather than as the figure it prints.

What this channel posts

Photos
≈7,750
Videos
≈13
Links
≈5,190

Lifetime counters from Telegram’s own channel header, read 12 November 2026 — not the date at the top of this page, which is when the subscriber count was last read. A count marked ≈ was rounded by Telegram before we ever saw it — t.me prints these counters in full below 1,000 and to three significant figures above, so ≈142,000 means somewhere between 141,500 and 142,499.

Recent posts

Telegram’s own ‘edited’ marker: 21 of 136 posts held from the last 30 days (15.4%) carried it when this register last read them. The marker says a post was changed after publishing, not what it said before — this register holds the earlier wording only where an edit fell between two of its own reads (see the edit ledger and how it is measured).

12 Nov 2026, 06:02 UTC≈1,540 viewsread 12 November 2026

https://www.fiercebiotech.com/biotech/will-we-see-10-chinese-big-pharmas-within-decade-some-ceos-think-so #헨리우스 #앱클론 미국 바이오 전문매체인 피어스바이오텍에서 빅파마 가능성이 있다고 예측하는 중국바이오텍 경영자들을 인터뷰했는데 앱클론 파트너사 헨리우스 내용도 있습니다. 현재 글로벌 임상 3상 약 5건을 자체적으로 추진하고 있습니다. 이 가운데 HLX22는 HER2 양성 위암 1차 치료에서 트라스투주맙과 항암화학요법, 키트루다 병용 여부를 포함한 현행 표준치료와 직접 비교하는 연구로 소개됐습니다. 헨리우스의 HLX22 양성 위암 1차 치료제 임상 3상 결과에 따라 엄청난 임팩트가 있을 것으로 예상합니다. 중국 임상 2상 결과는 mPFS, mOS 미…

Signed 스토너

12 Nov 2026, 02:21 UTC≈2,600 viewsread 12 November 2026
Photo

#인제니아테라퓨틱스 머크가 26년4월부터 글로벌 3상 4천명 임상비용 1조이상 태우고있잖아요? 그동안 우리나라에서 독자로 했던 회사들 티슈진+메지온+HLB +신라젠+헬릭스미스등 엄청나게 갔던거 기억하시죠? 예전에 얀센이 유한양행 오스코텍 폐암 1차치료제 개발해줘서 유한양행 오스코텍이 괜찮았는데요 지금 탑빅파마 머크가 FDA 3상 4천명 임상비용 1조이상 투자는 대한민국 바이오 역사상 최초의 재료입니다. 최초라는점만 기억하면됩니다. 아~ 이게 숙성이되면 내년에 인제니아테라퓨틱스 3상 성공 기대감에 얼마나 가치를 평가받을까? 지금 1조인데 내년에도 1조에 살 수 있을까요? 그냥 이런종목은 내릴때마다 사실 사모으면 내년에 큰 기쁨을 줄 유력종목이라고 자신하고 있습니다.

Signed 팔칠사공

12 Nov 2026, 01:55 UTC≈1,100 viewsread 12 November 2026

안녕하세요 디앤디파마텍입니다. 당사는 금일 공시를 통해 차세대 알파 방사성 치료제 개발 관계사인 Z-Alpha의 후속 투자 참여를 발표했습니다. 이와 관련한 보도자료를 공유 드립니다. 디앤디파마텍, 美 관계사 지알파(Z-Alpha) 투자 참여, 약 100억원 규모 지분 직접 취득 ▶️오비메드·타이번캐피탈 등 기존 3대 주주 공동 참여 ▶️다국적 제약사 전략적 투자자로 합류, 아스타틴-211 기반 알파 방사성 치료제 잠재력 확인 [2026-11-12] GLP-1 계열 신약 개발 전문기업 디앤디파마텍(347850, 대표 이슬기)은 12일 이사회를 열고 미국 관계사 지알파 홀딩스(Z-Alpha Holdings, Inc., 이하 지알파)가 발행하는 신주 4,299,965주를 약 100억원에 취득하기로 결정했다고 공시했다. 지알파는 차세대 표…

Signed 팔칠사공

12 Nov 2026, 01:54 UTC≈1,640 viewsread 12 November 2026

📌 디앤디파마텍(시가총액: 1조 9,985억) #A347850 📁 타법인주식및출자증권취득결정 2026.11.12 10:54:37 (현재가 : 43,450원, +1.05%) 취득회사 : Z-Alpha Holdings, Inc. (미국) 주요사업 : 의약품 연구개발업 취득금액 : 100억 자본대비 : 10.91% 시총대비 : 0.5% - 취득 후 지분율 : 4.75% 예정일자 : 2026-11-16 취득목적 : 미국 알파 방사성 치료제 개발사 자금조달 참여를 통한 영향력 강화 * 취득방법 현금취득 공시링크: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261112900320 종목공시 : https://www.awakeplus.co.kr/disclosure/347850

Signed 팔칠사공

12 Nov 2026, 00:15 UTC≈1,590 viewsread 12 November 2026
Photo

후보 적응증으로 여전히 MS, MG 등을 언급하고 있습니다.

Signed 스토너

12 Nov 2026, 00:15 UTC≈1,230 viewsread 12 November 2026
Photo

안녕하세요 에이프릴바이오입니다. 전일 룬드벡의 3분기 실적발표가 있었습니다. APB-A1의 차기 적응증은 아직 확정되지 않았으나 여전히 룬드벡의 파이프라인 포트폴리오에 있음을 확인하였습니다. 적응증이 확정되는대로 공유드리겠습니다.

Signed 스토너

11 Nov 2026, 23:38 UTC≈3,280 viewsread 12 November 2026

알테오젠 적용 키트루다SC, 中 허가 6주 만에 추가 신청…적응증 확대 착수 알테오젠의 피하주사(SC) 전환 기술이 적용된 키트루다SC가 중국 첫 허가 이후 추가 적응증 확대에 들어갔다. 지난 9월 19개 고형암 적응증으로 허가받은 지 약 6주 만에 새로운 품목허가 신청이 접수됐다. 12일 중국 의약품 등록정보에 따르면 MSD는 지난 9일 펨브롤리주맙 피하주사제의 추가 품목허가를 신청했다. 이번 신청은 중국 치료용 생물의약품 등록분류 가운데 '2.2류'로 접수됐다. 출처 : https://www.medicopharma.co.kr/news/articleView.html?idxno=70376

Signed 팔칠사공

11 Nov 2026, 23:32 UTC≈1,890 viewsread 12 November 2026

💪 한미약품, 비만 '근육보존' 두 번째 카드 공개 — HM500197 (美 비만학회 ObesityWeek 2026 초록, 11/14~17 워싱턴DC) 1️⃣ 왜 근육인가 GLP-1 계열 비만약은 살과 함께 근육(제지방)도 빼서 감량의 '질'이 떨어짐 한미는 5~6년 전부터 '근육'에 베팅해 왔음 8월 근육보존 신약 HM17321을 로슈에 기술이전(계약금 1.9억달러) → HM500197이 그 후속 카드 2️⃣ 경쟁 구도 이 분야 대표 주자는 릴리 '비마그루맙'(항체) 약점: 근육 성장을 막는 마이오스타틴만이 아니라 다른 신호까지 같이 막아 근육 선택성이 떨어짐 항체라서 펩타이드 비만약과 한 제형으로 묶기 어려움 3️⃣ HM500197 차별점 3가지 ① 펩타이드 기반 주 1회 피하주사 → 기존 비만약과 복합제·병용 설계에 유리 ② 골…

Signed 팔칠사공

11 Nov 2026, 23:09 UTC≈1,750 viewsread 12 November 2026

#한미약품 1/2/3중 작용제, UCN2, 마이오스타틴 등 황금라인업!

Signed 스토너

11 Nov 2026, 23:08 UTC≈1,340 viewsread 12 November 2026

한미약품(Hanmi Pharmaceutical)이 비만 근육보존(muscle preserving) 포트폴리오에서 그 다음 키워드로, 근골격근(skeletal muscle) 선택적인 마이오스타틴 저해제(myostatin Inhibitor)라는 키워드를 본격적으로 꺼내들고 있습니다. 한미약품은 비만에서 5~6년전부터 근육이라는 키워드에 베팅해왔고, 올해 8월 로슈에 계약금 1억9000만달러 규모에 UCN2(urocortin-2) 유사체 ‘HM17321’를 라이선스아웃(L/O)했는데요. 그리고 이제는 후속 근육보존 에셋으로 펩타이드(peptide) 기반의 마이오스타틴 저해제 ‘HM500197’에 대한 전략을 점점 더 드러내고 있습니다. 비만에서 마이오스타틴 저해제 개발은 현재 일라이릴리(Eli Lilly)의 타입2 액티빈 수용체(type II …

Signed 스토너

11 Nov 2026, 22:51 UTC≈2,410 viewsread 12 November 2026

#뷰노 뷰노가 금융감독원의 증권신고서 정정신고서 제출 요구로 인해 대규모 유상증자 일정이 전면 연기됐다. 이에 따라 최대주주이자 대표이사가 계획했던 신주인수권증서 매각 계획도 함께 철회됐다. 12일 금융감독원 전자공시시스템에 따르면 뷰노는 금융감독원으로부터 주주배정 후 실권주 일반공모 유상증자에 대한 증권신고서 정정신고서 제출 요구를 받았다. 금융당국의 이번 정정 요구는 투자자들이 기업의 재무 상태나 공모 구조를 정확히 파악하고 합리적인 투자 판단을 내릴 수 있도록 신고서의 기재 내용이나 산정 근거 등을 보다 엄격히 보완하라는 취지로 풀이된다. 금감원 규정에 따라 증권신고서에 대한 정정 요구가 발생하면 해당 신고서의 효력은 즉시 정지된다. 이에 따라 뷰노는 당초 예정되었던 주요 일정을 모두 '추후 확정'으로 변경했다. 당초 뷰노의 계획에 …

Signed 팔칠사공

11 Nov 2026, 22:28 UTC≈2,110 viewsread 12 November 2026
Photo

Photo, posted without a caption

Signed 팔칠사공

Showing the 12 most recent of 511 posts we hold for @stoner8740. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Posts edited after publishing

@stoner8740 edited 1 post after it first published — the same permalink now carries different wording than the one this register originally read, caught because our own crawl held a copy of the earlier text.

An edit is not deception. Typo fixes, price updates and corrections look exactly like this too — this register can tell you the wording changed and when, not why. How this is measured.

First edit seen
9 August 2026
Most recent edit
9 August 2026

Forward network

Republishes

Channels on the register whose posts this channel has forwarded.

[신한 리서치본부] 제약/바이오
@bio_shinhan · 21,335
7 posts
에이프릴바이오 공식IR채널: 리레이팅 2026
@aprilbioipr · 4,394
6 posts
BioMoment
@BioMomentOncology · 1,084
4 posts
텐베거 인생을 위하여
@decapitationforces · 1,359
4 posts
🧬바이오섹터 분석🧬 [그로쓰리서치]
@growthbio · 13,338
4 posts
더파마 뉴스·인사이트| THE PHARMA
@BBAinsights · 1,136
3 posts
앱클론 IPR
@abclonipr · 1,688
3 posts
AWAKE - 실시간 주식 공시 정리채널
@darthacking · 65,571
3 posts
디앤디파마텍 공식 IR 채널
@dndpharmatech · 3,614
3 posts
한경바이오인사이트
@hkbioinsight · 4,257
3 posts
나혼주
@nahonju · 2,205
3 posts
더바이오 뉴스룸
@thebio111 · 6,540
3 posts
한양증권 제약/바이오 오병용
@bdragon0808 · 13,488
2 posts
미래에셋 제약/바이오 김승민
@bioksm · 14,998
2 posts
작업중이양
@eyang92 · 7,918
2 posts
💰월급으로부터해방💶
@freedomfromsalary · 728
2 posts
올릭스(주) - OliX Pharmaceuticals
@olix_official · 3,863
2 posts
순대렐라의 바이오 하우스
@BIOWORLDJD · 4,084
1 post
MJ의 Bio & Healthcare
@BarbarianBHC · 4,868
1 post
바이오파마봇 레이더 v1.0
@BiopharmaBot_News · 362
1 post
[Public] 파이낸스 스코프
@FS_public_channel · 828
1 post
지아이이노베이션 공식 IR
@GIInnovation · 2,117
1 post
하나증권 리서치
@HanaResearch · 25,158
1 post
한투 제약/바이오 위해주
@KIS_Healthcare · 8,685
1 post
Plan G Research
@Plan_G_Research · 6,328
1 post
TNBfolio
@TNBfolio · 25,163
1 post
Yeouido Lab_여의도 톺아보기
@Yeouido_Lab · 43,450
1 post
에임드바이오IR_Official
@aimedbio_official · 211
1 post
1년에 1랩업
@fordouble · 2,665
1 post
[충간지의 글로벌 의료기기/디지털 헬스/로보틱스 연구소]
@globalmedtech · 12,054
1 post
한국경제
@hankyung_fin · 12,689
1 post
현대차증권_리서치센터_채널
@hmsecresearch · 8,764
1 post
호그니엘
@hogniel · 15,455
1 post
허혜민의 제약/바이오 소식통
@huhpharm · 24,264
1 post
마켓타임스 뉴스룸
@markettimesnews · 121
1 post
BUY(!)BUY(!)바이오🤡DS 제약/바이오 김민정
@mnJeong_BIO · 8,069
1 post
NH 리서치 [제약/바이오]
@nhis_bio · 4,940
1 post
요약하는 고잉
@one_going · 48,283
1 post
Rafiki research
@rafikiresearch · 20,656
1 post
알지노믹스 공식 IR/PR 채널
@rznomics · 1,239
1 post
스몰인사이트리서치
@smallinsightresearch · 5,828
1 post

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

Named by 1 registered channel — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.

Named by

Channels on the register whose posts name this channel's handle.

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 12 November 2026 — this entry's latest reading, not the date you are reading this.

“팔칠사공스토너 실전투자 인사이트” (@stoner8740), 10,873 subscribers as measured 12 November 2026. Telegram Register, tgregister.com/channel/stoner8740.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.